Despite a rapidly growing tumor in his hypopharynx, Nguyen Luong Loi refuses hospitalization and endures severe pain to save ...

Studies published in 2025 reveal personalized treatments and a drug combination that helped metastatic breast cancer patients live longer without disease progression.

An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent. The study identifies and resolves molecular "bottlenecks" that have ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...

But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...

On Thursday, President Donald Trump unveiled TrumpRx, a government-hosted portal that directs patients to discounted, cash-priced prescription drugs offered by participating manufacturers and pharmacy ...

President Donald Trump is launching a website dedicated to providing discounts on medicine. The White House announced the debut of TrumpRx.gov on Feb. 5, where "patients will be able to access large ...

FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is clinically necessary. Complete DPD deficiency markedly impairs 5-FU ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.